JY
SRTA

Jeff Yass’s Strata Critical Medical Inc SRTA Stock Holding History

Jeff Yass’s Portfolio SRTA Stock Details SRTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.25M Buy
427,000
+139,400
+48% +$733K ﹤0.01% 6218
2026
Q1 		$1.2M Buy
287,600
+3,000
+1% +$14.4K ﹤0.01% 7412
2025
Q4 		$1.37M Sell
284,600
-117,600
-29% -$569K ﹤0.01% 6457
2025
Q3 		$2.04M Buy
402,200
+184,700
+85% +$816K ﹤0.01% 5761
2025
Q2 		$877K Buy
217,500
+155,000
+248% +$504K ﹤0.01% 7768
2025
Q1 		$171K Buy
62,500
+39,800
+175% +$143K ﹤0.01% 11105
2024
Q4 		$96.5K Buy
+22,700
New +$86.4K ﹤0.01% 11371
2024
Q2 		– Sell
-20,400
Closed -$58.1K – 12058
2024
Q1 		$58.1K Buy
20,400
+1,100
+6% +$3.39K ﹤0.01% 11498
2023
Q4 		$68.1K Sell
19,300
-40,500
-68% -$116K ﹤0.01% 11563
2023
Q3 		$155K Buy
59,800
+10,700
+22% +$37.6K ﹤0.01% 10518
2023
Q2 		$193K Buy
49,100
+200
+0.4% +$635 ﹤0.01% 10306
2023
Q1 		$165K Buy
48,900
+13,200
+37% +$53.8K ﹤0.01% 10820
2022
Q4 		$128K Sell
35,700
-11,500
-24% -$49.1K ﹤0.01% 10696
2022
Q3 		$190K Sell
47,200
-19,100
-29% -$98.1K ﹤0.01% 10918
2022
Q2 		$296K Sell
66,300
-69,900
-51% -$504K ﹤0.01% 9591
2022
Q1 		$1.16M Sell
136,200
-207,000
-60% -$1.45M ﹤0.01% 6762
2021
Q4 		$3.03M Sell
343,200
-168,100
-33% -$1.6M ﹤0.01% 4623
2021
Q3 		$5.32M Buy
511,300
+165,600
+48% +$1.45M ﹤0.01% 3841
2021
Q2 		$3.63M Sell
345,700
-70,500
-17% -$696K ﹤0.01% 4643
2021
Q1 		$4.28M Buy
+416,200
New +$5.79M ﹤0.01% 4210

Other funds holding SRTA

TP
Third Point New York $4.68B AUM 37.3% 1-Year Est. Return
NRCM
Northern Right Capital Management Darien, Connecticut $337M AUM 63.03% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AIC
AWM Investment Company New York $1.15B AUM 201.65% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59.9B AUM 27.01% 1-Year Est. Return
PLC
Pillsbury Lake Capital San Francisco, California $366M AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Jeff Yass's SRTA Position: Q2 2026 in Review

Jeff Yass reduced its Strata Critical Medical Inc (SRTA) stake by 57% in Q2 2026, selling an estimated $79.7K and leaving 11,510 shares worth $60.7K. The position accounts for ﹤0.01% of the portfolio, ranked #12757.

Jeff Yass first reported a position in SRTA in Q1 2021 and has held it in 22 quarters since. The position peaked at $3.74M in Q1 2021. 139 funds tracked by Wall St. Rank hold SRTA as of Q2 2026.

  • Jeff Yass held 11,510 shares of Strata Critical Medical Inc worth $60.7K as of Q2 2026.
  • Jeff Yass sold 15,151 Strata Critical Medical Inc shares in Q2 2026, an estimated $79.7K.
  • Strata Critical Medical Inc made up ﹤0.01% of Jeff Yass's portfolio in Q2 2026, its #12757 holding.
  • Jeff Yass first reported a position in Strata Critical Medical Inc in Q1 2021 and has held it in 22 quarters since.
  • Jeff Yass's Strata Critical Medical Inc position peaked at $3.74M in Q1 2021.
  • 139 funds tracked by Wall St. Rank held Strata Critical Medical Inc as of Q2 2026.

Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.